Denis Schmartz

Denis Schmartz

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2021 in Journal of Clinical Monitoring and Computing
Verified
Journal Article
Closed access
PDF file
TSThomas Edward Saliba
Thomas Edward Saliba
DSDenis Schmartz
Denis Schmartz
JFJ.-F. Fils
J.-F. Fils
PLP. Van Der Linden
P. Van Der Linden

9 March 2019 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
SCSean Coeckelenbergh
Sean Coeckelenbergh
ADAmélie Delaporte
Amélie Delaporte
DGDjamal Ghoundiwal
Djamal Ghoundiwal
JBJavad Bidgoli
Javad Bidgoli
JFJean-François Fils
Jean-François Fils
PLPhilippe Van der Linden
Philippe Van der Linden
Goal-directed fluid therapy (GDFT) based on dynamic indicators of fluid responsiveness has been shown to decrease postoperative complications and hospital length of stay (LOS) in patients undergoing major abdominal surgery. The usefulness of this approach still needs to be clarified in low-to-moderate risk abdominal surgery. Both pulse-pressure variation (PPV) and pleth variability index (PVI) can be used to guide GDFT strategies. The objective of this prospective randomized controlled trial was to determine if the use of PVI guided GDFT, when compared to PPV guided GDFT, would lead to similar hospital LOS in patients undergoing low-to-moderate risk surgery. Secondary outcomes included amount of fluid administered and incidence of postoperative complications. Patients were randomized into either PVI or PPV guided GDFT groups. Both received a baseline 2 ml kg− 1 h− 1 Lactated Ringer infusion. Additional fluid boluses consisted of 250 mL of colloid that was infused over a 10 min period if PVI was > 15% or PPV was > 13% for at least five minutes. The primary outcome was to determine if hospital LOS, which was defined as the number of days from surgery up to the day the surgeon authorized hospital discharge, was equivalent between the two groups. A total of 76 patients were included and they were randomized into two groups of 38 patients. Baseline characteristics were similar in both groups. Both PVI and PPV guided GDFT strategies were equivalent for the primary outcome of LOS (median [interquartile range]) (days) 2.5 [2.0–3.3] vs. 3.0 [2.0–5.0], p = 0.230, respectively. Fluids infused, postoperative complications, and all other outcomes were not different between groups. In patients undergoing low-to-moderate risk abdominal surgery, PVI seems to guide GDFT similarly to PPV in regards to hospital LOS, amount of fluid, and incidence of postoperative complications. However, in low-risk patients undergoing these surgical procedures optimizing stroke volume may have limited impact on outcome. ClinicalTrials.gov Identifier: NCT02908256 , September 2016, retrospectively registered.

27 March 2017 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
OVOmbeline Empis de Vendin
Ombeline Empis de Vendin
DSDenis Schmartz
Denis Schmartz
LBLaurent Brunaud
Laurent Brunaud
TFThomas Fuchs‐Buder
Thomas Fuchs‐Buder

28 August 2019 in Trials
Verified
Journal Article
Open access
PDF file
Sébastien RIMBERTSébastien RIMBERT
Sébastien RIMBERT
DSDenis Schmartz
Denis Schmartz
LBLaurent Bougrain
Laurent Bougrain
CMClaude Meistelman
Claude Meistelman
CBCédric Baumann
Cédric Baumann
PGPhilippe Guerci
Philippe Guerci
Accidental Accidental awareness during general anesthesia (AAGA) occurs in 1–2% of high-risk practice patients and is a cause of severe psychological trauma, termed post-traumatic stress disorder (PTSD). However, no monitoring techniques can accurately predict or detect AAGA. Since the first reflex for a patient during AAGA is to move, a passive brain-computer interface (BCI) based on the detection of an intention of movement would be conceivable to alert the anesthetist. However, the way in which propofol (i.e., an anesthetic commonly used for the general anesthesia induction) affects motor brain activity within the electroencephalographic (EEG) signal has been poorly investigated and is not clearly understood. For this reason, a detailed study of the motor activity behavior with a step-wise increasing dose of propofol is required and would provide a proof of concept for such an innovative BCI. The main goal of this study is to highlight the occurrence of movement attempt patterns, mainly changes in oscillations called event-related desynchronization (ERD) and event-related synchronization (ERS), in the EEG signal over the motor cortex, in healthy subjects, without and under propofol sedation, during four different motor tasks. MOTANA is an interventional, prospective, exploratory, physiological, monocentric, and randomized study conducted in healthy volunteers under light anesthesia, involving EEG measurements before and after target-controlled infusion of propofol at three different effect-site concentrations (0 μg.ml −1, 0.5 μg.ml −1, and 1.0 μg.ml −1). In this exploratory study, 30 healthy volunteers will perform 50 trials for the four motor tasks (real movement, motor imagery, motor imagery with median nerve stimulation, and median nerve stimulation alone) in a randomized sequence. In each conditions and for each trial, we will observe changes in terms of ERD and ERS according to the three propofol concentrations. Pre- and post-injection comparisons of propofol will be performed by paired series tests. MOTANA is an exploratory study aimed at designing an innovative BCI based on EEG-motor brain activity that would detect an attempt to move by a patient under anesthesia. This would be of interest in the prevention of AAGA. Agence Nationale de Sécurité du Médicament (EUDRACT 2017-004198-1), NCT03362775. Registered on 29 August 2018. https://clinicaltrials.gov/ct2/show/NCT03362775?term=03362775&rank=1

20 July 2020 in Journal of Clinical Monitoring and Computing
Verified
Journal Article
Closed access
PDF file
DSDenis Schmartz
Denis Schmartz
LCLaura Chénard
Laura Chénard
CBCédric Baumann
Cédric Baumann
TFThomas Fuchs-Buder
Thomas Fuchs-Buder

13 September 2021 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
DSDenis Schmartz
Denis Schmartz
RSRaouf Sghaier
Raouf Sghaier
PBPaul Bernard
Paul Bernard
JFJean François Fils
Jean François Fils
TFThomas Fuchs-Buder
Thomas Fuchs-Buder
An increasing number of patients older than 80 years are undergoing anesthesia, but little information is available regarding pharmacodynamic effects of myorelaxants in this population. This study aims to compare the time course of rocuronium neuromuscular block in patients ≥ 80 years with those of younger adults. Under total intravenous anesthesia with propofol and sufentanil, time course of a bolus of rocuronium 0.6 mg/kg neuromuscular block was assessed with acceleromyography in patients ≥ 80 and in patients 20–50 years old. Onset time, clinical duration, duration until 90% and 100% recovery of baseline were determined. Data from 32 patients were analyzed, 16 were ≥ 80 years and 16 were 20–50 years old. Demographic data are shown in Table 1. In the group ≥ 80, onset time was 190 s ± 46 s compared to 123 s ± 40 s in the group 20–50, P < 0.001 and the clinical duration was 52 [48–69.5] min and 36 [34–41] min, respectively, P < 0.001. Duration to 90% recovery of baseline was 77.5 [71–88.5] min and duration to 100% recovery of baseline was 91.2 [82.2–98] min in patients ≥ 80 years and the corresponding values in the patients 20–50 years old were 53.5 [49–55.5] min and 59.5 [56.5–70.25] min, respectively, P < 0.001. Compared to younger adults rocuronium shifted in patients ≥ 80 years from a rapid onset, intermediate acting compound to a slower onset, long-acting compound. ClinicalTrials.gov identifier: NCT03551652 (29/05/2018).